Zymeworks Inc. financial data

Symbol
ZYME on Nasdaq
Industry
Pharmaceutical Preparations
Location
108 Patriot Drive, Suite A, Middletown, Delaware
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Zymeworks Delaware Inc. (to 10/13/2022)
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574 %
Debt-to-equity 29.1 %
Return On Equity -28.4 % -156%
Return On Assets -22 %
Operating Margin -294 % -847%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.6M shares +10%
Common Stock, Shares, Outstanding 70.7M shares +10.3%
Entity Public Float 469M USD +53.1%
Common Stock, Value, Issued 1B USD +11.4%
Weighted Average Number of Shares Outstanding, Basic 76.2M shares +14.2%
Weighted Average Number of Shares Outstanding, Diluted 76.2M shares +14.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 50.5M USD -88.7%
Research and Development Expense 130M USD -32.4%
General and Administrative Expense 69.3M USD -11.4%
Costs and Expenses 199M USD -26.3%
Operating Income (Loss) -149M USD -184%
Nonoperating Income (Expense) -103K USD -111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -128M USD -169%
Income Tax Expense (Benefit) -1.88M USD -115%
Net Income (Loss) Attributable to Parent -126M USD -173%
Earnings Per Share, Basic -1.78 USD/shares -165%
Earnings Per Share, Diluted -1.77 USD/shares -165%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 115M USD -36.8%
Accounts Receivable, after Allowance for Credit Loss, Current 30.9M USD -53.7%
Assets, Current 394M USD -7.64%
Deferred Income Tax Assets, Net 3.7M USD +164%
Property, Plant and Equipment, Net 19M USD -19.3%
Operating Lease, Right-of-Use Asset 17.1M USD -23.5%
Goodwill 12M USD 0%
Assets 554M USD -7.82%
Employee-related Liabilities, Current 2.54M USD -59%
Contract with Customer, Liability, Current 3.44M USD +46.2%
Liabilities, Current 56.9M USD -15.5%
Contract with Customer, Liability, Noncurrent 32.9M USD +7.69%
Deferred Income Tax Liabilities, Net 3.35M USD +80.6%
Operating Lease, Liability, Noncurrent 21M USD -12%
Other Liabilities, Noncurrent 1.59M USD -55.7%
Liabilities 116M USD -9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.72M USD -30.1%
Retained Earnings (Accumulated Deficit) -709M USD -21.6%
Stockholders' Equity Attributable to Parent 438M USD -7.51%
Liabilities and Equity 554M USD -7.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.7M USD +54.7%
Net Cash Provided by (Used in) Financing Activities 2.12M USD +22.2%
Net Cash Provided by (Used in) Investing Activities -7.32M USD +94.7%
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 70.7M shares +10.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.7M USD +80.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 115M USD -36.8%
Deferred Tax Assets, Valuation Allowance 222M USD +54.1%
Deferred Tax Assets, Gross 235M USD +50%
Operating Lease, Liability 25.1M USD -7.67%
Depreciation 1.06M USD -33%
Payments to Acquire Property, Plant, and Equipment 185K USD -52.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -128M USD -174%
Lessee, Operating Lease, Liability, to be Paid 29.5M USD -7.98%
Property, Plant and Equipment, Gross 40.5M USD +6.55%
Operating Lease, Liability, Current 4.16M USD +23.2%
Deferred Income Tax Expense (Benefit) -757K USD -139%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.4M USD -9.7%
Deferred Tax Assets, Operating Loss Carryforwards 597M USD +89.8%
Preferred Stock, Shares Issued 1 shares 0%
Current Income Tax Expense (Benefit) 189K USD -97.9%
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 3.08M USD +0.46%
Operating Lease, Payments 5.1M USD +17.5%
Preferred Stock, Shares Outstanding 1 shares 0%
Amortization of Intangible Assets 702K USD +3.39%
Deferred Tax Assets, Net of Valuation Allowance 3.62M USD +169%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%